The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 140, No 8, 1025-1026.
© 2009 American Dental Association

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chung, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, M.
Related Collections
Right arrow Pharmacology

RESEARCH

Prescription of Antibiotics for Prophylaxis to Prevent Bacterial Endocarditis



Mina Chung, DDS, MS


   Clinical question.
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 
Does prophylactic antibiotic administration before invasive dental procedures in people at increased risk of bacterial endocarditis influence mortality, serious illness or endocarditis incidence?


   Review methods.
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 
The authors conducted a comprehensive search of six electronic databases from 1950 through June 2008. The initial search identified 980 abstracts of which the authors reviewed 118 full articles. The authors excluded 83 articles because they were discussion articles, editorials or guidelines and 34 articles because they were duplicate studies. They included one article, which was a case-control study.


   Main results.
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 
The one study that was included reported on all cases of endocarditis in the Netherlands during a two-year period from November 1986 through November 1988, according to the authors. In the study, the authors defined cases as patients who had a predisposing cardiac disease and had undergone a medical or dental procedure with a definite or possible indication for prophylaxis and developed endocarditis within 180 days of this procedure. In the study, control patients had one of the following pre-existing conditions: congenital heart defect, history of rheumatic fever, high risk of developing endocarditis with prosthetic heart valves or a history of endocarditis. Control patients were matched for age and had undergone a medical or dental procedure with a definite or possible indication for prophylaxis and had not developed endocarditis within 180 days of the procedure. Indications for "definite prophylaxis" were dental extraction and "dental root work," and an indication for "possible prophylaxis" was dental scaling.

Of 349 patients who developed native-valve endocarditis, 44 had undergone dental treatment with a definite or possible indication for prophylaxis. Seven of these patients had been treated with prophylactic antibiotics before the dental procedure. Of the patients meeting the criteria for the control group, 181 had undergone a dental procedure with a definite or possible indication for prophylaxis. Seventeen of the control patients had been administered prophylactic antibiotics before they underwent the dental procedure. The odds of development of endocarditis among those receiving antibiotic prophylaxis was 1.62 (95 percent confidence interval, 0.57–4.57).

The authors did not locate any studies that assessed mortality, illness or other adverse effects. Since no conclusive evidence supporting a benefit was identified, the authors did not look for information on harms.


   Conclusion.
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 
There is no evidence that antibiotic prophylaxis is effective or ineffective against bacterial endocarditis when it is administered before an invasive dental procedure in people who are at risk of developing the disease.


   COMMENTARY
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 
Importance and context. Bacterial endocarditis is a serious, but rare, condition that can be caused by bacteria from the oral cavity. The clinical practice of antibiotic prophylaxis to prevent endocarditis has been evolving for more than 50 years. The objective is to prevent endocarditis arising from transient bacteremia that may be caused by dental procedures. Antibiotic prophylaxis recommendations are based largely on expert opinions and limited evidence. No clinical evidence has established a link between antibiotic prophylaxis and the prevention of bacterial endocarditis in at-risk patients.

Recently, the American Heart Association and the National Institute for Health and Clinical Excellence in the United Kingdom have reviewed guidelines for antibiotic prophylaxis. Current American Heart Association guidelines recommend antibiotic prophylaxis in patients with underlying cardiac conditions associated with the highest risk of adverse outcomes from endocarditis who undergo dental procedures that involve the manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa.1 In contrast, the National Institute for Health and Clinical Excellence does not recommend antibiotic prophylaxis for any at-risk patient undergoing a dental procedure unless there is suspected infection.2 Differences in such recommendations have caused much debate and continue to stir controversy in the international medical and dental communities.

Strengths and weaknesses of the systematic review. The review’s authors used accepted methods to identify and select studies. The authors also assessed the internal and external validity of the case-control study. The review’s authors recognized the limitations of basing conclusions on one observational study with retrospective case-control design. Although the case-control study analyzed medical and dental procedures separately, the authors of the systematic review provided the analysis.

Strengths and weaknesses of the evidence. One case-control study constitutes a weak body of evidence. The selected study was based in the Netherlands over a two-year period. A randomized controlled trial would be a challenge owing to the relatively low incidence of endocarditis in the general population and to bioethical considerations.

Implications for dental practice. The review of the evidence provides no definite conclusion about the administration of antibiotic prophylaxis to patients before they undergo dental procedures in an effort to prevent bacterial endocarditis. The global community continues to deliberate about the efficacy of antibiotic prophylaxis in the prevention of bacterial endocarditis. Until more evidence is available or a universally accepted guideline is established, practitioners in the United States should continue to follow the most recent American Heart Association guidelines on antibiotic regimens for dental procedures.1


   FOOTNOTES
 

A critical summary of Oliver R, Roberts GJ, Hooper L, Worthington, HV. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008;(4):CD003813.


Systematic review conclusion. There is no evidence that antibiotic prophylaxis before dental procedures is effective or ineffective against bacterial endocarditis in patients already at risk of developing the disease.


Critical summary assessment. On the basis of evidence from one case-control study, no definite conclusion can be drawn on the usage of antibiotic prophylaxis before dental procedures.


Evidence quality rating. Limited.


Dr. Chung is a clinical assistant professor, Department of Pediatric Dentistry, College of Dentistry, University of Illinois at Chicago, 801 S. Paulina St., M/C 850, Chicago, Ill. 60612, e-mail "minachungdds{at}yahoo.com". She also is an evidence reviewer for the American Dental Association. Address reprint requests to Dr. Chung.


The systematic review described here was funded by Central Manchester and Manchester Children’s University Hospital National Health Service Trust, England; The University of Manchester, England; Eastman Dental Institute, London; Department of Health Cochrane Review Incentive Scheme 2007, Oxford, England.


Critical Summaries is supported by grant 1 G08 LM008956 from the National Library of Medicine and the National Institute of Dental and Craniofacial Research.


These summaries, published under the auspices of the American Dental Association Center for Evidence-Based Dentistry, are prepared by practitioners trained in critical appraisal of published systematic reviews who work under the mentorship of experts. The summaries are not intended to, and do not, express, imply or summarize standards of care, but rather provide a concise reference for dentists to aid in understanding and applying evidence from the referenced systematic review in making clinically sound decisions as guided by their clinical judgment and by patient needs.


For more information on the evidence quality rating provided above and additional critical summaries, please visit "http://ebd.ada.org".


   REFERENCES
 TOP
 Clinical question.
 Review methods.
 Main results.
 Conclusion.
 COMMENTARY
 REFERENCES
 

  1. Wilson W, Taubert K, Gewitz M, et al.; Prevention of infective endocarditis: guidelines from the American Heart Association—a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group (published correction appears in JADA 2008;139[3]:253). JADA 2008;139(1 suppl):3S–24S.[Abstract/Free Full Text]

  2. National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. NICE Clinical Guideline 64. London: NICE; 2008. "www.nice.org.uk/CG064". Accessed June 16, 2009.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Chung, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, M.
Related Collections
Right arrow Pharmacology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS